We are live on ! Find out more
EW icon

Edwards Lifesciences
EW

1,259 hedge funds and large institutions have $39.4B invested in Edwards Lifesciences in 2025 Q2 according to their latest regulatory filings, with 164 funds opening new positions, 423 increasing their positions, 458 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more first-time investments, than exits

New positions opened: 164 | Existing positions closed: 93

70% more call options, than puts

Call options by funds: $254M | Put options by funds: $149M

8% more capital invested

Capital invested by funds: $36.6B → $39.4B (+$2.79B)

5% more funds holding

Funds holding: 1,204 → 1,259 (+55)

0% more funds holding in top 10

Funds holding in top 10: 10 → 10 (0)

0.57% less ownership

Funds ownership: 86.28% → 85.71% (-0.57%)

8% less repeat investments, than reductions

Existing positions increased: 423 | Existing positions reduced: 458

Holders
1,259
Holders Change
+55
Holders Change %
+4.57%
% of All Funds
16.58%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
164
Increased
423
Reduced
458
Closed
93
Calls
$254M
Puts
$149M
Net Calls
+$105M
Net Calls Change
+$25.1M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$359M
2
DZ Bank
DZ Bank
Germany
+$358M
3
Marshall Wace
Marshall Wace
United Kingdom
+$288M
4
Millennium Management
Millennium Management
New York
+$241M
5
Jennison Associates
Jennison Associates
New York
+$118M

Top Sellers

Rank Fund Capital Flow
1
Fisher Asset Management
Fisher Asset Management
Washington
-$730M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$694M
3
UBS AM
UBS AM
Illinois
-$396M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$120M
5
American Century Companies
American Century Companies
Missouri
-$78.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
HHMI
1151
Howard Hughes Medical Institute
Maryland
$9.93K +$9.47K +127 New
PWA
1152
Provenance Wealth Advisors
Florida
$9.78K – – –
FGA
1153
Fortis Group Advisors
New Jersey
$9.38K – – –
WAS
1154
Winch Advisory Services
Wisconsin
$9.38K – – –
BCM
1155
Boreal Capital Management
Florida
$9.38K +$8.95K +120 New
WA
1156
Whipplewood Advisors
Colorado
$9.23K -$1.49K -20 -14%
PK
1157
Pflug Koory
Nebraska
$8.53K – – –
NFSG
1158
Newbridge Financial Services Group
Florida
$8.29K -$7.46K -100 -49%
AGWCA
1159
Annis Gardner Whiting Capital Advisors
Florida
$8.21K – – –
WWM
1160
Wolff Wiese Magana
California
$8.06K – – –
TWD
1161
True Wealth Design
Ohio
$8.06K +$1.64K +22 +27%
CAM
1162
Close Asset Management
United Kingdom
$8K – – –
OAJ
1163
Ogorek Anthony Joseph
New York
$8K +$1.42K +19 +20%
NRG
1164
Nemes Rush Group
Michigan
$7.98K +$447 +6 +6%
HNW
1165
High Note Wealth
Minnesota
$7.9K -$373 -5 -5%
TFA
1166
Toth Financial Advisory
Virginia
$7.82K – – –
MAM
1167
Morse Asset Management
Connecticut
$7.82K +$7.46K +100 New
IRC
1168
Investors Research Corp
Georgia
$7.35K – – –
APW
1169
Aventura Private Wealth
Florida
$7.2K – – –
CB
1170
CNB Bank
Pennsylvania
$6.96K – – –
S
1171
Sachetta
Massachusetts
$6.88K +$4.4K +59 +203%
AWM
1172
Abound Wealth Management
Tennessee
$6.8K +$2.61K +35 +67%
RF
1173
Robinswood Financial
Washington
$6.8K – – –
KG
1174
Kilter Group
New York
$6.57K +$6.26K +84 New
DIP
1175
DT Investment Partners
Pennsylvania
$6.34K – – –
45 46
47
48 49

EW Hedge Fund Activity: Q2 2025 in Review

1,259 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2025, worth a combined $39.4B — up 7.6% from $36.6B a quarter earlier.

Buyers outnumbered sellers: 164 funds opened new EW positions and 93 closed out — a net gain of 71 holders — while 423 added to existing stakes and 458 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $359M. The largest seller was Fisher Asset Management, cutting an estimated $730M.

  • 1,259 institutional investors held Edwards Lifesciences (EW) as of Q2 2025, up from 1,204 in Q1 2025.
  • Funds reported $39.4B of Edwards Lifesciences stock for Q2 2025, up 7.6% quarter-over-quarter.
  • 164 funds opened new Edwards Lifesciences positions in Q2 2025 and 93 closed out, a net change of +71 holders.
  • The largest Edwards Lifesciences buyer in Q2 2025 was JP Morgan Chase, an estimated $359M added.
  • The largest Edwards Lifesciences seller in Q2 2025 was Fisher Asset Management, an estimated $730M sold.

Based on aggregated 13F filings for Q2 2025.